ZUG, Switzerland, May 30, 2011 /PRNewswire/ -- NovaShunt AG has launched a new corporate identity and product brandingto support its goal of leadership in the area of fluid management within the body. The company will now operate as Sequana Medical AG ( http://www.sequanamedical.com) as it prepares for the upcoming launch of the ALFApump(TM) System in Europe.
NovaShunt's first product is the Automated Low-Flow Ascites (ALFA) Pump System, a subcutaneously implanted battery-powered pump system that removes excess abdominal fluid, known as ascites, by transferring it to the bladder where it is eliminated through normal urination. Ascites is a common complication in patients suffering from liver cirrhosis, certain cancers and congestive heart failure.
"The ALFApump System has tremendous potential as a new therapeutic tool for the management of fluid overload. Patients with persistent or refractory ascites are faced today with poor treatment options that negatively impact quality of life. Also, the healthcare system bears a very heavy burden of care for these patients. We believe the ALFApump System can offer patients the relief of fewer repeat interventions and better quality of life while saving money and resources," stated Dan Rose, Vice President of Commercial Operations.
The rebranding was undertaken with the advice of milani design & consulting (http://www.milani.ch), a leading Swiss design firm. Sequana is an ancient name which refers to the springs at the source of the river Seine which were believed to have healing properties.
"As we prepare for the launch of our first product, we look forward to introducing ourselves to physicians and patients as Sequana Medical. The ALFApump System is the first clinical application of our core technology and a very exciting step for the company. We look forward to making the name 'Sequana Medical' known for offering patients better options and better outcomes in the field of fluid management," concluded Dr. Johnson.
About Sequana Medical
Sequana Medical is a Swiss medical device company dedicated to improving patient lives through innovative technologies to manage fluid within the body.
Dan Rose +41-44-446-5070 email@example.com
SOURCE NovaShunt AG
Subscribe to our Free Newsletters!
This is a branch of telemedicine that delivers eye care via a digital medical equipment and ...
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...View All